TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

AMNEAL

OncologyCardiovascularInfectious Disease
Generics

AMNEAL is a generic drug manufacturer focused on Oncology, Cardiovascular, Infectious Disease. Key products include CYCLOPHOSPHAMIDE.

1992
Since
179
Drugs
-
Trials
1498
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 28%
17 drugs
Cardiovascular 26%
15 drugs Phase 3: 1 Phase 1: 1
Infectious Disease 17%
10 drugs
Immunology 15%
9 drugs
Dermatology 13%
8 drugs

Pipeline Strength Pro

Loading...